ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th

(firmenpresse) - DOYLESTOWN, PA -- (Marketwire) -- 11/02/11 -- ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the third quarter, ended September 30, 2011, will be released before the market opens on Wednesday, November 9th. A shareholder's conference call will be held later that morning on November 9th, at 11:00am EST. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and third quarter results. There will be a question and answer session following initial remarks.

The conference call will be webcast live at:
at 11:00 AM (EST) on Wednesday, November 9, 2011.

Participants wishing to ask questions may access the live call by dialing (877) 217-6026 conference ID # 21014476 A replay of the conference call will be available for 90 days on the company website .



ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels. For more information visit us at .



Press Only Contact:
Jenny Miranda
5W Public Relations

Tel: (212) 584-4295


Investor Relations:
Ted Karkus
Chairman of the Board, CEO
(215) 345-0919 x0

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 02.11.2011 - 12:30 Uhr
Sprache: Deutsch
News-ID 82988
Anzahl Zeichen: 0

contact information:
Town:

DOYLESTOWN, PA

Kategorie:

Personal Care & Fitness

Diese Pressemitteilung wurde bisher 196 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th"
steht unter der journalistisch-redaktionellen Verantwortung von

ProPhase Labs (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended Sept ...

DOYLESTOWN, PA -- (Marketwired) -- 11/12/15 -- (NASDAQ: PRPH) () today reported its net sales were $4.4 million for the three months ended September 30, 2015, as compared to net sales of $5.1 million for the three months ended September 30, 2014. T ...

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June ...

DOYLESTOWN, PA -- (Marketwired) -- 08/12/15 -- (NASDAQ: PRPH) () today reported its net sales were $2.2 million for the three months ended June 30, 2015, as compared to net sales of $1.8 million for the three months ended June 30, 2014. The Company ...

ProPhase Establishes 3.2 Million Share Equity Line ...

DOYLESTOWN, PA -- (Marketwired) -- 08/05/15 -- ProPhase Labs, Inc. (NASDAQ: PRPH) () announced today that as of July 30, 2015, it entered into an Investment Agreement (the "Investment Agreement") with Dutchess Opportunity Fund, II, LP, a D ...

Alle Meldungen von ProPhase Labs